{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:28Z","timestamp":1791295648972,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.coi.2009.05.018","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T05:48:15Z","timestamp":1244699295000},"page":"308-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"title":["Yellow fever vaccine \u2014 how does it work and why do rare cases of serious adverse events take place?"],"prefix":"10.1016","volume":"21","author":[{"given":"Alan DT","family":"Barrett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E","family":"Teuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.coi.2009.05.018_bib1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.vaccine.2006.12.015","article-title":"17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005","volume":"25","author":"Barrett","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.coi.2009.05.018_bib2_1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.coi.2009.05.018_bib3_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.coi.2009.05.018_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"issue":"Pt 1","key":"10.1016\/j.coi.2009.05.018_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.coi.2009.05.018_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2009.05.018_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.coi.2009.05.018_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","article-title":"Detection of Th1\/Th2 cytokine signatures in yellow fever 17DD first-time vaccines through ELISpot assay","volume":"42","author":"Santos","year":"2008","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.coi.2009.05.018_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.coi.2009.05.018_bib10_1","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.coi.2009.05.018_bib11_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.coi.2009.05.018_bib12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Yellow Fever Working Group","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.coi.2009.05.018_bib13_1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"15","key":"10.1016\/j.coi.2009.05.018_bib14","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.coi.2009.05.018_bib15","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2009.05.018_bib16_1","first-page":"285","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"issue":"16","key":"10.1016\/j.coi.2009.05.018_bib17","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.vaccine.2007.01.078","article-title":"Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999\u20132005","volume":"25","author":"Fernandes","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.coi.2009.05.018_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum Vaccine"},{"issue":"11","key":"10.1016\/j.coi.2009.05.018_bib19_1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","author":"Bae","year":"2008","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.coi.2009.05.018_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":"Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","author":"Veit","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"50","key":"10.1016\/j.coi.2009.05.018_bib21_1","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.coi.2009.05.018_bib22_1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.coi.2009.05.018_bib23","first-page":"23","article-title":"Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases","volume":"42","author":"da Mota","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"issue":"43","key":"10.1016\/j.coi.2009.05.018_bib24","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1016\/j.vaccine.2008.06.025","article-title":"International laboratory network for yellow fever vaccine-associated adverse events","volume":"26","author":"Barrett","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.coi.2009.05.018_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0074-02762007000100020","article-title":"The sample processing time interval as an influential factor in flow cytometry analysis of lymphocyte subsets","volume":"102","author":"dos Santos","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791509000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791509000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:22:34Z","timestamp":1760602954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791509000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0952791509000995"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2009.05.018","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yellow fever vaccine\u2014how does it work and why do rare cases of serious adverse events take place?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2009.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}